Mefenamic Acid Market _ Global Industry Report, 2031

1. 9/2/22, 12:47 PM Mefenamic Acid Market | Global Industry Report, 2031 Search report Keywords Home / Chemicals And Materials / Chemicals / Mefenamic Acid Market Mefenamic Acid Market Rep Id : TMRGL84264 Mefenamic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021- Upcoming 2031 Chemicals And Materials Report Preview Request Methodology Transparency Plus Request ToC COVID-19 Impact on Global Mefenamic Acid Market On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the Coronavirus disease (COVID-19) outbreak a public health emergency of international concern. Originating in China, the virus has spread to at least 214 countries and territories around the world. Several governments and private sector businesses are operating at a limited capacity or have ceased operations completely due to recent events surrounding the COVID-19 pandemic The outbreak of the COVID-19 pandemic has led to disturbance in the supply chain due to the global lockdown in several countries. The spread of coronavirus has led to a fall in demand for chemical intermediates due to uncertainty in the global economy and capital markets. Growth of the mefenamic acid market has been hampered due to the COVID- 19 pandemic and lockdown of several non-essential activities and manufacturing facilities in most countries. However, the market is anticipated to expand at a healthy pace during the forecast period due to the acceptance of new normal conditions and recovery of various end-use industries in many countries. Select License Type Single User license $5795 Multi-User license $8795 Corporate license $11795 Pre Book Safe and Secure SSL Encrypted Get A Special pricing for start-ups and universities. Request Discount - Need More Info? - Key Drivers and Restraints of Mefenamic Acid Market Enquiry Before Buying Demand for mefenamic acid is expected to increase at a significant pace during the forecast period due to the increase in prevalence of dysmenorrhea, and rise in level of awareness and growth in concern about dysmenorrhea among women in developed countries. Most women tend to have dysmenorrhea during puberty, typically within four to five years of the first menstrual cycle. Prostaglandins are chemicals produced in the lining of the uterus during menstruation. These prostaglandins trigger muscle contractions in the uterus, which cause discomfort and reduce the flow of blood and oxygen to the uterus. Mefenamic acid helps reduce menstrual pain. The side effects of mefenamic acid are negatively affecting the mefenamic acid market. Mefenamic acid causes side effects including nausea, tiredness, itching, upper stomach pain, flu-like symptoms (fever, chills, body aches), severe skin redness, itching, and peeling. Request Methodology Ask References Free Customization - Want to customize this report? - We employ Market Analysis, Benchmarking, Corporate Intelligence, and Technological Intelligence to understand specific requirements and customize report with a quick turnaround time in a dynamic business environment. We offer 100% Free Customisation at the time of purchase Mefenamic Acid Market: Application Segment Connect To Analyst Based on application, the global mefenamic acid market can be divided into hospitals, drug stores, and others The hospital segment dominates the mefenamic acid market Mefenamic acid is available in the form of capsule. Mefenamic acid capsules are a member of the fenamates group of nonsteroidal anti-inflammatory drugs (NSAIDs). In hospitals, it is used to treat mild to moderate pain and dysmenorrhea - Trusted Partners - https://www.transparencymarketresearch.com/mefenamic-acid-market.html 1/4

2. 9/2/22, 12:47 PM Mefenamic Acid Market | Global Industry Report, 2031 North America to Hold Leading Share of Global Mefenamic Acid Market Quick Contact 866-552-3453 In terms of region, the mefenamic acid market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa North America is expected to hold major share of the global mefenamic acid market, followed by Asia Pacific and Europe, during the forecast period As per a study published in the Indian Journal of Research, about US$ 2 Bn or 600 million working hours are lost annually in the U.S. due to incapacitating dysmenorrhea. Furthermore, women who attend classes or work have been shown to have lower work output or scores during their dysmenorrhea. Increase in research and development for innovative drugs and the presence of well-established health care infrastructure in the U.S. are fuelling the market in North America. +1-518-618-1030 Contact by email Why trust Us? 35,000+ Research Reports - Related Reports - Floating Liquefied Natural Gas (FLNG) Terminals Market Automotive Composite Material Market Glue Dispenser Market Key Manufacturers Operating in Global Mefenamic Acid Market Glass Ceramics Market The mefenamic acid market was consolidated in 2020. Major players have prominent presence Fuel Tank Sealants Market in developed and developing countries. Key manufacturers operating in the mefenamic acid market include: Shionogi Pharma Solitaire Pharmacia Shinto Organics Captab EMS Pharma Adelco Agron Remedies IASIS Pharmaceuticals Hellas ABL Lifecare Farmo Quimica Apotex Sanofi Aventis Yung Sine Streuli Pharma, Mankind Pfizer Daiichi Sankyo Koa Isei Teva Wockhardt Esteve Mefenamic Acid Market: Research Scope Mefenamic Acid Market, by Type Patent Generic Mefenamic Acid Market, by Application Hospitals Drug Stores Others Global Mefenamic Acid Market, by Region North America U.S. Canada https://www.transparencymarketresearch.com/mefenamic-acid-market.html 2/4

3. 9/2/22, 12:47 PM Mefenamic Acid Market | Global Industry Report, 2031 Europe Germany U.K. France Italy Spain Russia & CIS Rest of Europe Asia Pacific China India Japan ASEAN Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa GCC South Africa Rest of Middle East & Africa Mefenamic Acid Market: Introduction Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID). It belongs to a class of drugs called beta-blockers. Systematic name of mefenamic acid is dimethylphenylaminobenzoic acid. Mefenamic acid works by reducing hormones that cause inflammation and pain in the body. It is used short-term (seven days or less) to treat mild to moderate pain in adults, and children who are at least 14 years old. Mefenamic acid is also used to treat menstrual pain. Mefenamic acid is a prescription medicine used to treat symptoms of high blood pressure (hypertension). It may be used alone or with other medications. Interested in this report? Get a FREE Brochure now! Request Brochure *Get Brochure (PDF) sent to your email within minutes - Help - - Follow Us - Terms Of UseCustomer FAQHow To OrderPrivacy PolicySitemap U.S Sales Office Corporate Headquarter Reach Us +1-518-618-1030 866-552-3453 (US-Canada Toll Free) https://www.transparencymarketresearch.com/mefenamic-acid-market.html 3/4

4. 9/2/22, 12:47 PM Mefenamic Acid Market | Global Industry Report, 2031 State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States Downtown, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA sales@transparencymarketresearch.com Trust Online Copyright © Transparency Market Research, Inc. All Rights reserved https://www.transparencymarketresearch.com/mefenamic-acid-market.html 4/4